Data Science and Analytics Technologies Header Image

 

Data Science & Analytics Technologies
データサイエンス・アナリティクステクノロジー

Tools and Methods for Extracting Insights and Value from Data to Advance Biomedical Research
データからインサイトや価値を引き出すツールと手法で、バイオメディカル研究を前進

2025年4月2日〜4日 米国東部標準時(EDT)

「データサイエンス・アナリティクステクノロジー」トラックでは、データサイエンティストがデータから深いインサイトを引き出し、価値を高めるために使用する最先端のツール、テクノロジー、手法について詳しく説明します。プレゼンテーションでは、スケーラブルなプラットフォームとパーソナライズされたアナリティクスソリューションへの移行に焦点を当て、データドリブン型組織を構築するための戦略を探り、データ管理とリアルタイムアナリティクスへの革新的なアプローチを検討します。また、データ調査の指針となるクリティカルな質問の組み立て方、実務的な場面におけるデータサイエンスの具体的な影響の評価、データサイエンスツールとそのアプリケーションにおける最新の進歩についても紹介します。これらのテクノロジーが、ライフサイエンスの研究や意思決定にどのような変革をもたらすのかを探るために、ぜひご参加ください。

4月2日(水)

Registration Open8:00 am

Recommended Pre-Conference Workshops and Symposia*9:00 am

On Wednesday, April 2, 2025, Cambridge Healthtech Institute is pleased to offer five pre-conference Workshops scheduled across two time slots (9:00 am–12:00 pm and 1:15–4:15 pm) and three Symposia from 9:00 am–4:20 pm. All are designed to be instructional, interactive, and provide in-depth information on a specific topic. They allow for one-on-one interaction and provide a great way to explain more technical aspects that would otherwise not be covered during the main conference tracks that take place Thursday–Friday.

*Separate registration required. See details on the Symposia here and details on the Workshops here.

4:40 pm

Organizer's Remarks

Cindy Crowninshield, Executive Event Director, Cambridge Healthtech Institute

4:45 pm Talk Title to be Announced

Speaker to be Announced, CLOVERTEX

4:55 pm PLENARY KEYNOTE PRESENTATION:

From Bytes to Breakthroughs: Generative AI Driving the Future of Life Sciences and Healthcare

Sofia Guerra, Vice President, Bessemer Venture Partners

Subha Madhaven, Vice President and Head, AI/ML, Quantitative and Digital Sciences, Global Metrics and Data Management, Pfizer Inc.

Generative AI has the potential to transform life sciences and deliver unprecedented insights, automation, and efficiency. But is it? This keynote panel brings together leaders from biopharma, healthcare, and emerging tech who are leveraging AI to advance drug discovery, diagnostics, and patient care. Panelists will share their own case studies and real-world applications and discuss how they’ve tackled challenges—both technical and cultural. Look beyond the hype curve to see how this technology is really being used now and where the next opportunities lie.

Welcome Reception in the Exhibit Hall with Poster Viewing (Sponsorship Opportunity Available)6:10 pm

The Bio-IT Kickoff Reception is a reunion—reconnect with friends, explore cutting-edge research, and celebrate innovation! Enjoy poster presentations, networking, and vote for the Best of Show and Poster awards.

Close of Day7:25 pm

4月3日(木)

Registration Open7:00 am

8:00 am

Organizer's Remarks

Allison Proffitt, Editorial Director, Bio-IT World and Clinical Research News

8:05 am Talk Title to be Announced

Speaker to be Announced, Snowflake Computing Inc

AI-POWERED PLATFORMS IN DRUG DISCOVERY: TACKLING ANTIBIOTIC RESISTANCE AND AGING THERAPEUTICS
創薬におけるAI活用のプラットフォーム:抗生剤耐性と老化治療への取り組み

8:15 am PLENARY KEYNOTE PRESENTATION:

Deep Learning for Antibiotic Discovery

James J. Collins, PhD, Termeer Professor, Medical Engineering & Science, Massachusetts Institute of Technology

In this presentation, we highlight the Antibiotics-AI Project, which is a multi-disciplinary, innovative research program that is leveraging MIT's strengths in artificial intelligence, bioengineering, and the life sciences to discover and design novel classes of antibiotics. The Antibiotics-AI Project is focused on developing, integrating, and implementing deep learning models and chemogenomic screening approaches: (1) to predict novel antibiotics from expansive chemical libraries with diverse properties, (2) to design de novo novel antibiotics based on learned structural and functional properties of existing and newly discovered antibiotics, and (3) to identify, using explainable deep learning models, the chemical structures and molecular mechanisms underlying the newly discovered and/or designed antibiotics. With these deep learning approaches, we are utilizing multi-scale computation to embrace and harness the complexity of biology and chemistry, so as to discover, design, and develop new classes of antibiotics, up through preclinical studies. Our platform has been designed so that it can be utilized and applied in a rapid fashion to emerging and re-emerging bacterial pathogens, including multidrug-resistant (MDR) bacteria and extensively drug-resistant (XDR) bacteria.

8:45 am PLENARY KEYNOTE PRESENTATION:

Generative AI, Aging Research and Robotics as a Platform for Drug Discovery: From Hype to Clinical Efficacy

Alex Zhavoronkov, PhD, Founder & CEO, Insilico Medicine

9:15 amSession Q&A

Coffee Break in the Exhibit Hall with Poster Viewing (Sponsorship Opportunity Available)9:30 am

Start your morning with coffee, connections, and cutting-edge research! Enjoy poster presentations, network in the Exhibit Hall, vote for awards, and a chance at a fabulous raffle prize!

Organizer's Welcome Remarks10:15 am

AI-POWERED TRANSFORMATION IN LIFE SCIENCES: DATA SCIENCE SOLUTIONS FOR REAL-WORLD IMPACT
ライフサイエンスにおけるAI活用のトランスフォーメーション:現実世界に影響を与えるデータサイエンスソリューション

Chairperson's Remarks (Sponsorship Opportunity Available)10:20 am

10:25 am

Data Science and AI in Biomedical Research: Bridging Analysis with Advanced Technologies

Parthiban Srinivasan, PhD, Professor and Director, Centre for AI in Medicine, Vinayaka Mission's Research Foundation, India

This talk explores the integration of data science and AI in biomedical research, focusing on four key types of data analysis: descriptive, exploratory, predictive, and prescriptive. We will discuss how these methods, combined with advanced technologies like knowledge graphs (using Neo4J) and large language models (LLMs) from HuggingFace, are transforming the way biomedical data is analyzed and interpreted, driving innovation in drug discovery and clinical research.

10:55 am

Accelerating Real-World Evidence Extraction with LLM-Optimized Bioinformatics Pipelines in the Human Omics Hub

Weiwei Schultz, PhD, Distinguished Scientist, Data Science and Digital Health, Johnson and Johnson Innovative Medicine

The Human Omics Hub focuses on integrating multi-omics data management, starting with the UK Biobank. However, fragmented pipelines hinder scalability. This study employs large language models (LLMs) to automate standardized Nextflow pipeline creation for multi-omics data processing. By merging LLMs with expert input, we optimized the development process, significantly reducing coding time and costs while accelerating real-world evidence generation from diverse omics data, including EHR and genomics.

11:25 am

Leveraging Supercomputing for in silico Human Heart Models in Cardiac Drug Safety

Mariano Vazquez, PhD, Co-Founder and CTO, ELEM Biotech, Barcelona, Spain

This presentation will explore the transformative potential of supercomputer-driven in silico trials for assessing cardiac drug safety. By employing advanced electrophysiological models of the human heart, we will demonstrate how these virtual trials can accurately predict drug-induced arrhythmias and QT interval prolongation, reducing reliance on traditional testing methods. Attendees will gain insights into integrating multi-scale modeling and AI into precision medicine, offering a scalable solution to enhance drug safety while minimizing costs and improving outcomes.

11:55 am

Enabling AI Workflows with Copyright

Michael Iarrobino, Director Product Management, Product Management, Copyright Clearance Center

Many AI systems depend on scientific, technical, and medical literature for model training and to support critical business workflows across numerous functions. As AI offerings mature, the intertwined responsibilities to copyright, data integrity, and data quality are essential to building user trust. This talk will explain key copyright considerations for your AI initiatives, identify solutions already available to address these needs, and set a vision for rights-aware AI systems that are able to achieve their promise.

Presentation to be Announced (Sponsorship Opportunity Available)12:10 pm

12:25 pm Talk Title to be Announced

Speaker to be Announced, ELSEVIER LTD

Session Break and Transition to Lunch12:55 pm

1:05 pm Talk Title to be Announced

Speaker to be Announced, ZS Associates

Refreshment Break in the Exhibit Hall with Poster Viewing (Sponsorship Opportunity Available)1:35 pm

Bio-IT's hall is bigger than ever—one break won’t cut it! Enjoy dessert and coffee after lunch, explore booths and posters, vote for awards, and participate in our raffle for a chance to win a prize!

UNLOCKING THE VALUE OF BIOMEDICAL DIGITAL TWINS: FROM CUTTING-EDGE TECHNOLOGIES IN BIOPHARMA R&D TO PERSONALIZED PATIENT CARE
バイオメディカルのデジタルツインの価値を解放:バイオファーマR&Dにおける最先端テクノロジーからパーソナライズされた患者ケアまで

2:25 pm

Chairperson's Remarks

Eric Stahlberg, PhD, Executive Administrative Director, Institute for Data Science in Oncology, MD Anderson Cancer Center

2:30 pm

Unlocking the Value of Biomedical Digital Twins: From Cutting-Edge Technologies in BioPharma R&D to Personalized Patient Care 

Douglas E. Kiehl, Senior Director, Disruptive & Transformative Technologies Team, Digital Twin COE, Eli Lilly & Co.

Andy Kilianski, PhD, Program Manager, Health Science Futures, ARPA-H

Eric Stahlberg, PhD, Executive Administrative Director, Institute for Data Science in Oncology, MD Anderson Cancer Center

Digital twin technology, already transformative in aerospace and energy, holds vast potential in biopharmaceutical R&D and personalized healthcare. By integrating extensive biomedical data, AI innovations, and precision medicine, digital twins can advance disease prediction, optimize treatments, and improve oncology and patient outcomes. Gain valuable insights into applying digital twins and predictive models within oncology and biopharma, addressing technical and data-related challenges, emerging AI uses, and future pathways that prioritize patient-centered care.

Presentation to be Announced (Sponsorship Opportunity Available)4:00 pm

Best of Show Awards Reception in the Exhibit Hall with Poster Viewing (Sponsorship Opportunity Available)4:30 pm

Unwind with colleagues at our lively reception! Explore posters, vote for the best, network with exhibitors, enjoy a drink, and try to win a raffle prize. Celebrate Best of Show winners!

Close of Day5:45 pm

4月4日(金)

Registration Open7:00 am

Quick Bytes & Networking Breakfast—Lifted Rooftop Restaurant & Bar (Sponsorship Opportunity Available)7:00 am

Start your morning with ‘Quick Bytes & Networking’! Enjoy a cozy restaurant-style setting, quick bites, and speed networking. Connect, converse, and energize your Bio-IT experience before the plenary keynote!

8:00 am

Organizer's Remarks

Cindy Crowninshield, Executive Event Director, Cambridge Healthtech Institute

8:05 am

Innovative Practices Awards: Excellence in Technological Innovation

Allison Proffitt, Editorial Director, Bio-IT World and Clinical Research News

The Innovative Practices Awards recognizes and celebrates technology innovation in the life sciences. Bio-IT World is currently accepting entries for the 2025 Innovative Practices Awards, a competition designed to recognize partnerships and projects pushing our industry forward. Winners will be announced in mid-March 2025, recognized during the Friday, April 4 Plenary Keynote Program, and scheduled to give a podium presentation about their project during the conference. For more details about the Awards and to submit an application, visit www.bioitworldexpo.com/innovativepractices.

8:20 am Talk Title to be Announced

Speaker to be Announced, Illumina

ADVANCING DRUG DISCOVERY AND HEALTHCARE THROUGH DATA-DRIVEN INNOVATION: FROM GENOMICS TO THERAPEUTICS
データドリブンのイノベーションによる創薬とヘルスケアの進歩:ゲノミクスから治療まで

8:30 am PLENARY KEYNOTE PRESENTATION:

Scaling Genomic Medicine: Transforming Newborn Screening through Informatics and Innovation

Robert C. Green, MD, MPH, Professor and Director of Genomes2People Research, Mass General Brigham, Broad Institute, Ariadne Labs and Harvard Medical School

The BabySeq Project has pioneered the integration of genomic sequencing into newborn and childhood screening, uncovering unexpected risk variants and transforming healthcare delivery. This keynote explores the groundbreaking progress in genomic medicine, featuring real-world stories of families impacted by these discoveries. Learn about the informatics challenges and innovative solutions required to scale genomic screening for national and global implementation, reshaping the future of precision medicine.

9:00 am PLENARY KEYNOTE PRESENTATION:

Unlocking the Power of Machine Learning and Data-at-Scale to Deliver with Speed the Best Therapeutic Candidates

Justin M. Scheer, PhD, Vice President In Silico Discovery & Head, Molecular Computational Team, Johnson & Johnson Innovative Medicine

The challenges of high costs, lengthy timelines, and significant attrition have prompted our industry to integrate AI/ML into all aspects of the business. This presentation highlights J&J's strategic investments in AI/ML technologies to enhance the drug discovery processes, including molecule design and optimization. By investing in these technologies with a modality agnostic approach, J&J aims to tackle the hardest targets in drug discovery, ultimately increasing the success rate of delivering better molecules faster.

9:30 amSession Q&A

Coffee Break in the Exhibit Hall with Poster Competition Winners Announced (Sponsorship Opportunity Available)9:45 am

Bio-IT is all about connections! Explore booths, award-winning posters, and network with clients, colleagues, and exhibitors. Grab coffee, build relationships, and stay for a chance to win a raffle prize!

Organizer's Remarks10:30 am

PATHWAYS TO IMPACT: DRIVING RESEARCH AND INNOVATION THROUGH INCLUSION AND DIVERSITY IN DATA SCIENCE AND LIFE SCIENCES TO ADVANCE HEALTH AND PRECISION MEDICINE
影響への道:データサイエンスとライフサイエンスにおける包摂と多様性を通じて研究とイノベーションを促進し、ヘルスと精密医療を推進

Chairperson's Remarks (Sponsorship Opportunity Available)10:35 am

10:40 am

Pathways to Impact: Driving Research and Innovation through Inclusion and Diversity in Data Science and Life Sciences to Advance Health and Precision Medicine

Jason Alexander, Chief Revenue Officer & Co-Founder, BANKW Staffing, LLC

Jared Auclair, PhD, Interim Dean, Northeastern University College of Professional Studies

Jason Beckwith, PhD, Professor, School of Business, University of Dundee

Carolina Benjaminsen, PhD, Senior Director, Head of Digital Science Academy, Digital Science & Innovation, R&ED, NovoNordisk

Kevin M. Ileka, PhD, Associate Director, Worldwide Immunology Communications, Bristol Myers Squibb Co.

Martin Leach, PhD, MBA, Chief Data Officer, Black Canyon Consulting LLC

This panel will examine how inclusion and diversity are essential for advancing research and innovation in data science and life sciences. By embracing diverse perspectives, organizations can boost innovation, enhance problem-solving, and attract top talent. Attendees will discover effective strategies for creating inclusive teams, the impact of diverse talent on research outcomes, and the advantages of diversity in navigating industry changes and improving health outcomes in precision medicine.

Presentation to be Announced (Sponsorship Opportunity Available)12:10 pm

Session Break and Transition to Lunch1:10 pm

Luncheon Presentation (Sponsorship Opportunity Available) or Enjoy Lunch on Your Own1:20 pm

Refreshment Break in the Exhibit Hall with Last Chance for Poster Viewing (Sponsorship Opportunity Available)1:50 pm

Feeling tired? Recharge during the final Networking Exhibit Hall break! Visit booths, explore posters, connect with peers, and turn in your Game Cards for a chance to win a raffle prize.

Chairperson's Remarks (Sponsorship Opportunity Available)2:30 pm

TRENDS FROM THE TRENCHES: BRIDGING TRADITIONAL INSIGHTS WITH INNOVATIVE ADVANCEMENTS
現場のトレンド:従来の見識と革新的な進歩の橋渡し

2:35 pm

Transforming Big Data into Actionable Insights: Leveraging the Sequence Read Archive (SRA) for Life Sciences and Public Health

J. Rodney Brister, PhD, Acting Program Head, Sequence Read Archive, NCBI, NLM, NIH

As the world's largest publicly available repository of raw sequence data, the Sequence Read Archive (SRA) plays a pivotal role in advancing public health and life sciences research. This presentation highlights state-of-the-art tools and strategies for managing and analyzing the SRA’s massive datasets, showcasing its impact on infectious disease surveillance, genomic epidemiology, and precision medicine. Discover how innovative informatics solutions are transforming raw data into actionable insights for global health challenges.

3:05 pm

Refactoring Research Systems with AI: Modernizing Code for Life Sciences Innovation

Cindy Crowninshield, Executive Event Director, Cambridge Healthtech Institute; Additional Speakers to be Confirmed

With AI taking center stage in coding, research teams are leveraging AI-enabled IDEs to refactor legacy systems into modern, efficient languages. This talk presents a balanced view of generative AI-supported coding, cutting through the hype to focus on real-world applications. Discover practical strategies and examples of how AI is transforming outdated research systems into scalable, maintainable, and future-ready platforms for life sciences.

3:35 pm

Trends from the Trenches

Ari E. Berman, PhD, CEO, BioTeam, Inc.

Since 2010, “Trends from the Trenches” has been a cornerstone of the Bio-IT program, delivering candid and occasionally blunt assessments of the most impactful and overhyped IT technologies in life sciences. This talk will provide a deep dive into computing, storage, cloud, data science, machine learning, and more, with a focus on supporting data-intensive science. Looking ahead, this talk will share forward-thinking predictions about emerging technologies and trends poised to shape the future of life sciences innovation, offering actionable insights for navigating the next wave of IT evolution.

Close of Conference4:05 pm

* 不測の事態により、事前の予告なしにプログラムが変更される場合があります。

Choose your language
Traditional Chinese
Simplified Chinese
Korean
English


会議の詳細はこちらをご参照ください